Brief: Reata Pharmaceuticals Q1 adjusted net income USD -67 million
10/05/2023 12:28
May 10 (Reuters) - Reata Pharmaceuticals Q1 adjusted net income USD -67 million. * Q1 revenue USD 195 thousand * Q1 net income USD -116.117 million
Recent news on Reata Pharmaceuticals
See all newsReata Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Reata Pharmaceuticals Inc expected to post a loss of $2.88 a share - Earnings Preview
Brief: Biogen Inc Says If Deal Terminated Under Certain Conditions, Reata Will Be Required To Pay Biogen Termination Fee Equal To $264 Mln
U.S. STOCKS ON THE MOVE-US regional banks, Enphase, Centene
Biogen’s $7 bln deal goes smaller and safer